|
You are here |
meassociation.org.uk | ||
| | | | |
sjogrens.org
|
|
| | | | | By Florian Kollert, MD Department of Rheumatology, Immunology, and Allergology, Inselspital, University Hospital Bern, Bern, Switzerland and Benjamin A. Fisher, MD Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre and Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. | |
| | | | |
www.yalemedicine.org
|
|
| | | | | Dr. Sanacora is a Professor of Psychiatry at Yale University and the Director of the Yale Depression Research Program. Dr. Sanacora's work has focused largely on elucidating the pathophysiological mechanisms associated with mood and other neuropsychiatric disorders and using this information to inform the development of novel treatment strategies. His preclinical research laboratory explores the effects of stress and pharmaceutical agents on cellular biology, neurophysiology and behavior. His clinical la... | |
| | | | |
virology.ws
|
|
| | | | | By David Tuller, DrPH Cochrane--formerly called the Cochrane Collaboration--is respected worldwide for its systematic reviews of medical treatments. These r ... | |
| | | | |
brighterworld.mcmaster.ca
|
|
| | | Update, March 3, 2022: Human clinical trials for these vaccines have begun and are ongoing. This story was originally published on Dec. 7, 2021. Human . . . | ||